Aquestive Therapeutics, Inc.·4

May 13, 1:40 PM ET

Wargacki Stephen 4

4 · Aquestive Therapeutics, Inc. · Filed May 13, 2024

Insider Transaction Report

Form 4
Period: 2024-05-10
Wargacki Stephen
Chief Science Officer
Transactions
  • Award

    Common Stock

    2024-05-10+10,000267,963 total
Footnotes (1)
  • [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Documents

1 file
  • 4
    marketforms-65653.xmlPrimary

    PRIMARY DOCUMENT